Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
carotenoid/atrophy
Link salvestatakse lõikelauale
Leht 1 alates 20 tulemused
Pharmaceutically active carotenoids
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The invention related to the use of lutein and zeaxanthin which increase the deposition of macular pigment in the human eye. The invention is particularly but not exclusively concerned with lutein and/or zeaxanthin for use in the treatment by therapy or prophylaxis of disease of the macula and in
Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
There are many disorders characterized by circulatory system problems:
Peripheral Vascular Disease
The circulatory system consists of two types of blood vessels, arteries and veins, which carry the blood throughout the body. Arteries carry oxygen- and nutrient-rich blood
Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
There are many disorders characterized by circulatory system problems:
Peripheral Vascular Disease
The circulatory system consists of two types of blood vessels, arteries and veins, which carry the blood throughout the body. Arteries carry oxygen- and nutrient-rich blood
Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to methods and compositions to alleviate eye diseases and, more specifically, to improved methods and compositions for the treatment of cataracts and macular degeneration.
2. Description of the Related
Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to methods and compositions to alleviate eye diseases and, more specifically, to improved methods and compositions for the treatment of cataracts and macular degeneration.
2. Description of the Related
Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
This invention is in the field of biochemistry, and relates to the creation and purification of a certain isomer of a carotenoid pigment called zeaxanthin (abbreviated as ZX), for use in preventing or treating macular degeneration, a disease which damages retinal tissue
Methods and compositions for treatment of macular and retinal disease
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to methods and compositions for treatment and prevention of disease, and in particular embodiments, disorders of the eye. In an embodiment, the present invention describes linking therapeutic compounds to xanthophyll carotenoids to enhance
Process for synthesis of (3R,3'R)-zeaxanthin and (3R,3'S;meso)-zeaxanthin from (3R,3'R,6'R)-lutein via (3R)-3',4'-anhydrolutein
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention is in the field of organic chemistry. The invention relates to a process for the synthesis of (3R,3'R)-zeaxanthin and (3R,3'S;meso)-zeaxanthin from a dehydration product of (3R,3'R,6'R)-lutein, namely,
Process for synthesis of (3R,3'R,6'R)-lutein and its stereoisomers
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention is in the field of organic chemistry. The invention relates to a process for the synthesis of (3R,3'R,6'R)-lutein and its stereoisomers from commercially available (rac)-.alpha.-ionone by a C.sub.15+C.sub.10+C.sub.15 coupling
Composition and methods for improving retinal health
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to a nutritional dietary supplement composition and related methods of administration for the treatment and/or prevention of retinal diseases, and their concomitant impairment of vision. In particular, the invention relates to a nutritional
Zeaxanthin formulations for human ingestion
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
This invention is in the field of pharmacology, and relates to human use of a yellow pigment called zeaxanthin (ZX) in preventing or treating macular degeneration, a disease which damages retinal tissue and causes blindness.
This application is being simultaneously filed
Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
This invention is in the field of biochemistry, and relates to the creation and purification of a certain isomer of a carotenoid pigment called zeaxanthin (abbreviated as ZX), for use in preventing or treating macular degeneration, a disease which damages retinal tissue
Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
This invention is in the field of biochemistry, pharmacology, and nutritional supplements, and relates to a new use for zeaxanthin, a carotenoid found in plants such as spinach, kale, and corn.
Numerous efforts have been made to identify drugs or other biomolecules that
Optical method and apparatus for determining status of agricultural products
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The invention relates to the determination of the freshness of agricultural crops, products, and forests, and in particular, to the determination of antioxidant content through optical methods.
BACKGROUND OF THE INVENTION
In plants, carotenoids act as accessory pigments in
Preloading with macular pigment to improve photodynamic treatment of retinal vascular disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention is in the field of medicine, and relates to administering a natural carotenoid pigment called zeaxanthin to patients who receive treatment using light-activated drugs to inhibit the unwanted growth of blood vessels in their retinas.
BACKGROUND OF THE
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
